Otros ingredientes: agente de carga (celulosa microcristalina), celulosa (HPMC), antiaglomerante (estearato de magnesio vegetal)
Who Should Avoid It Dont use semaglutide if you have: Personal or family history of medullary thyroid carcinoma (a specific thyroid cancer) Multiple endocrine neoplasia syndrome type 2 Any pregnancy plans (stop at least 2 months before trying to conceive) Talk to your doctor if you have a history of pancreatitis, kidney disease, diabetic retinopathy, or gallbladder problems
Mode of action of orlistat
The cognitive benefit data is preliminary but compelling, and the longevity medicine community is watching that research space closely
Regulatory Status and Absence of Human Safety Data As of 2026, retatrutide has not received approval from the MHRA, FDA, EMA, or any other regulatory authority for human use
TRIUMPH-4 (28.7% weight loss, knee OA population, December 2025), TRIUMPH-1 (28.3%, general obesity, May 2026), TRANSCEND-T2D-1 (-2.0% HbA1c, 16.8% weight loss, June 2026), TRIUMPH-2 (20.8% weight loss, obesity + diabetes, July 23, 2026), and TRIUMPH-3 (22.6% weight loss, obesity + cardiovascular disease, July 23, 2026) have all reported positive results